Viral Vector News and Research

RSS
Viral Vector is a type of virus used in cancer therapy. The virus is changed in the laboratory and cannot cause disease. Viral vectors may produce tumor antigens (proteins found on a tumor cell) to stimulate an antitumor immune response in the body. Viral vectors may also be used to carry genes that can change cancer cells back to normal cells.
Even mild SARS-CoV-2 respiratory-only infection can cause long-term neurologic damage

Even mild SARS-CoV-2 respiratory-only infection can cause long-term neurologic damage

Insignificant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens

Insignificant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens

Virus-like particles as delivery vehicles for gene-editing

Virus-like particles as delivery vehicles for gene-editing

Distrust in state power closely linked vaccine hesitancy

Distrust in state power closely linked vaccine hesitancy

Exploring vaccine-induced cellular immunity against SARS-CoV-2 Omicron variant

Exploring vaccine-induced cellular immunity against SARS-CoV-2 Omicron variant

Reviewing myocarditis and pericarditis in immunosuppressed individuals following COVID-19 mRNA vaccination

Reviewing myocarditis and pericarditis in immunosuppressed individuals following COVID-19 mRNA vaccination

Ad5-nCoV vaccine safe and effective against symptomatic, severe COVID-19, trials shows

Ad5-nCoV vaccine safe and effective against symptomatic, severe COVID-19, trials shows

Protein-based nanoparticle vaccines for protection against SARS-CoV-2

Protein-based nanoparticle vaccines for protection against SARS-CoV-2

Effect of T cell reactivity in COVID-19 infection and vaccination

Effect of T cell reactivity in COVID-19 infection and vaccination

Risk of Guillain-Barré syndrome decreases after COVID-19 vaccination

Risk of Guillain-Barré syndrome decreases after COVID-19 vaccination

Booster vaccination can reduce breakthrough infection risk in HIV patients

Booster vaccination can reduce breakthrough infection risk in HIV patients

Immunogenicity and safety of COVID-19 subunit vaccine Nanocovax in animal models

Immunogenicity and safety of COVID-19 subunit vaccine Nanocovax in animal models

Study reveals how a protein in the blood is attracted to key component of Adenovirus-based vaccines

Study reveals how a protein in the blood is attracted to key component of Adenovirus-based vaccines

SARS-CoV-2 vaccine based on vesicular stomatitis virus exhibits high neutralizing efficacy against variants

SARS-CoV-2 vaccine based on vesicular stomatitis virus exhibits high neutralizing efficacy against variants

Real-world effectiveness and safety of COVID-19 vaccines

Real-world effectiveness and safety of COVID-19 vaccines

Study shows neutralizing capacity of monoclonal antibodies against SARS-CoV-2 variants of concern

Study shows neutralizing capacity of monoclonal antibodies against SARS-CoV-2 variants of concern

COVID-19 vaccination and deaths amongst US veterans

COVID-19 vaccination and deaths amongst US veterans

Study finds benefits of COVID vaccination in pregnancy outweighs risks

Study finds benefits of COVID vaccination in pregnancy outweighs risks

COVID-19 vaccine-elicited immune responses in myeloma patients

COVID-19 vaccine-elicited immune responses in myeloma patients

COVID-19 vaccination side effects in the USA

COVID-19 vaccination side effects in the USA